TNF Pharmaceuticals, Inc. Financial Flexibility Index
TNF Pharmaceuticals, Inc. financial flexibility index. TNF Pharmaceuticals, Inc. (TNFA) has a Financial Flexibility Index of -0.37x as of June 2025. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $3.00) represents 0% of total liabilities ($5.55 Million). See cash generation quality of TNF Pharmaceuticals, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of TNF Pharmaceuticals, Inc. (2004–2024)
Financial flexibility index of TNF Pharmaceuticals, Inc. from 2004 to 2024. Historical Financial Flexibility Index trend for TNF Pharmaceuticals, Inc. across 21 annual periods. Check TNF Pharmaceuticals, Inc. (TNFA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
TNF Pharmaceuticals, Inc. Financial Flexibility Index by Year (2004–2024)
TNF Pharmaceuticals, Inc. financial flexibility index by year from 2004 to 2024. Year-by-year free cash flow to debt coverage for TNF Pharmaceuticals, Inc.. For the full cash flow conversion analysis, see TNF Pharmaceuticals, Inc. cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.34x | $-8.98 Million | $-8.98 Million | $6.70 Million | ▲ +47.5% |
| 2023 | -2.55x | $-12.98 Million | $-12.98 Million | $5.09 Million | ▲ +40.9% |
| 2022 | -4.31x | $-12.27 Million | $-12.27 Million | $2.84 Million | ▲ +74.2% |
| 2021 | -16.74x | $-19.52 Million | $-19.52 Million | $1.17 Million | ▼ -712.5% |
| 2020 | -2.06x | $-4.66 Million | $-4.66 Million | $2.26 Million | ▼ -2.5% |
| 2019 | -2.01x | $-3.07 Million | $-3.07 Million | $1.53 Million | ▲ +53.1% |
| 2018 | -4.28x | $-8.45 Million | $-8.52 Million | $1.97 Million | ▼ -52.1% |
| 2017 | -2.82x | $-5.03 Million | $-5.08 Million | $1.79 Million | ▼ -18.0% |
| 2016 | -2.39x | $-4.05 Million | $-4.17 Million | $1.70 Million | ▲ +20.7% |
| 2015 | -3.01x | $-5.02 Million | $-5.13 Million | $1.67 Million | ▼ -43.7% |
| 2014 | -2.09x | $-3.86 Million | $-3.88 Million | $1.84 Million | ▼ -56.8% |
| 2013 | -1.33x | $-2.61 Million | $-2.73 Million | $1.95 Million | ▼ -174.0% |
| 2012 | -0.49x | $-1.03 Million | $-1.04 Million | $2.11 Million | ▲ +84.2% |
| 2011 | -3.08x | $-2.20 Million | $-2.26 Million | $714.78K | ▼ -166.2% |
| 2010 | -1.16x | $-1.47 Million | $-1.73 Million | $1.27 Million | ▼ -1.4% |
| 2009 | -1.14x | $-1.31 Million | $-1.38 Million | $1.15 Million | ▼ -267.8% |
| 2008 | 0.68x | $677.88K | $469.37K | $996.00K | ▲ +2411.9% |
| 2007 | 0.03x | $203.19K | $182.19K | $7.50 Million | ▲ +102.9% |
| 2006 | -0.92x | $-5.24 Million | $-5.31 Million | $5.67 Million | ▲ +14.5% |
| 2005 | -1.08x | $-5.53 Million | $-5.61 Million | $5.11 Million | ▼ -13.4% |
| 2004 | -0.95x | $-4.08 Million | $-4.10 Million | $4.28 Million | — |